NEW PRODUCT: COGNIVAID™

 Moleac has just launched a new product, CognivAiD™,  in Singapore!

A Focus on Neurology

Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide. 

Our products are developed by Moleac with scientific excellence and evidence-based approach.

Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide. 

A growing international network

Patients taking NeuroAid yearly

Awards

Countries with Exclusive Partnership

Let’s talk about moleac with noemie & david picard

Moleac in a nutshell. Noemie, 9 years old, gets to know more about Moleac with David Picard, its co-founder and CEO. 

Latest News